For evaluating the risk posed by hazardous substances in humans and the environment, a central problem is analysis. Immunoassays are finding their place among more established methods for measurement of toxic materials in the environment and have a predominant role in human monitoring. Advantages of immunoassays include speed of analysis, cost-effectiveness, sensitivity, specificity, applicability to a wide variety of compounds and adaptability to laboratory or field situations. This proposal has three objectives. The first is to develop rapid, inexpensive assays for hazardous substances and environmental degradation products. Lack of such assays affects site evaluation and limits the development of good models for groundwater movement, human exposure, and research on remediation systems. Several compound classes have been identified for assay development in this proposal. Triazine herbicides are good indicators of agricultural contamination. Assay development for this class of compounds will continue our targets such as prometon, the 2- hydroxy and mono and didealkylated metabolites in order to develop a battery of assays for parents and metabolites. 2,3,7,8- Tetrachlorodibenzodioxin is a compound whose impact in human and environmental health is still subject to debate and is a prime example of a compound for which analysis costs are extremely high. Developing specific immunoassays will be a challenge to the synthetic chemist. In such as lead and cadmium have also been targeted. Levels of contamination have not even begun to be addressed due to the unique problems in sample preparation and analysis. The second objective is to develop assays to assess human exposure and effect. Development of these assays is intimately tied to an understanding of the mechanistic basis of toxicity and also will provide new reagents for probing such fundamental mechanisms. In collaboration with other workers markers for and the mechanisms of cellular toxicity will be addressed. Specifically proposed targets include triazine mercapturates (urinary metabolites of triazines), nitrophenols (metabolites of some industrial intermediates, explosives and organophosphate insecticides), naphthalene mercapturate (urinary metabolites of naphthalene), relaxin (an indicator of occult pregnancy) and the 14K Clara cell protein (an example of a target protein that may be specifically involved in cellular toxicity). Our third objective is the development of new immunochemical technologies for use in the environmental field. Techniques will be developed to interface immunoassay with classical analytical procedures such as utilizing antibodies for affinity separation and cleanup or as detectors following classical cleanup (i.e. supercritical fluid extraction). Use of expert systems in the implementation of immunochemical detection into environmental chemistry will be evaluated. Statistical consideration for analysis of optimum assay strategies, low analyte concentration and multianalyte problems will be developed.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Harris, Todd R; Kodani, Sean; Rand, Amy A et al. (2018) Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury. Mol Pharmacol 94:834-841
Bever, Candace S; Rand, Amy A; Nording, Malin et al. (2018) Effects of triclosan in breast milk on the infant fecal microbiome. Chemosphere 203:467-473
Zheng, Jing; McKinnie, Shaun M K; El Gamal, Abrahim et al. (2018) Organohalogens Naturally Biosynthesized in Marine Environments and Produced as Disinfection Byproducts Alter Sarco/Endoplasmic Reticulum Ca2+ Dynamics. Environ Sci Technol 52:5469-5478
Lakkappa, Navya; Krishnamurthy, Praveen T; Yamjala, Karthik et al. (2018) Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development. J Pharm Biomed Anal 149:457-464
Guedes, A G P; Aristizabal, F; Sole, A et al. (2018) Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis. J Vet Pharmacol Ther 41:230-238
Heikenfeld, J; Jajack, A; Rogers, J et al. (2018) Wearable sensors: modalities, challenges, and prospects. Lab Chip 18:217-248
Minaz, Nathani; Razdan, Rema; Hammock, Bruce D et al. (2018) An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats. Prostaglandins Other Lipid Mediat 136:84-89
Lassabe, Gabriel; Kramer, Karl; Hammock, Bruce D et al. (2018) Noncompetitive Homogeneous Detection of Small Molecules Using Synthetic Nanopeptamer-Based Luminescent Oxygen Channeling. Anal Chem 90:6187-6192
?ertíková Chábová, V?ra; Kujal, Petr; Škaroupková, Petra et al. (2018) Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Kidney Blood Press Res 43:329-349
Kodani, Sean D; Bhakta, Saavan; Hwang, Sung Hee et al. (2018) Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase. Bioorg Med Chem Lett 28:762-768

Showing the most recent 10 out of 1149 publications